Concerns About Genetic Risk Testing for Opioid Use Disorder

Simple item page
dc.contributor.authorHatoum, Alexander S.
dc.contributor.authorDavis, Christal N.
dc.contributor.authorKember, Rachel L.
dc.contributor.authorJohnstone, Mandy
dc.contributor.authorOslin, David W.
dc.contributor.authorZinkstok, Janneke R.
dc.contributor.authorBurmeister, Margit
dc.contributor.authorEthics, Position, and Public Policy Committee of the International Society of Psychiatric Genetics
dc.contributor.authorBoard of Directors of the International Society of Psychiatric Genetics
dc.contributor.authorAgrawal, Arpana
dc.contributor.authorKranzler, Henry R.
dc.contributor.authorEdenberg, Howard J.
dc.contributor.authorGelernter, Joel
dc.contributor.authorDocherty, Anna R.
dc.contributor.authorLencz, Todd
dc.contributor.departmentBiochemistry and Molecular Biology, School of Medicine
dc.date.accessioned2025-07-16T13:34:27Z
dc.date.available2025-07-16T13:34:27Z
dc.date.issued2025
dc.eprint.versionAuthor's manuscript
dc.identifier.citationHatoum AS, Davis CN, Kember RL, et al. Concerns about genetic risk testing for opioid use disorder. Lancet Psychiatry. 2025;12(2):94-95. doi:10.1016/S2215-0366(24)00310-9
dc.identifier.urihttps://hdl.handle.net/1805/49518
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/S2215-0366(24)00310-9
dc.relation.journalThe Lancet: Psychiatry
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectGenetic testing
dc.subjectAddictive disorder
dc.subjectRisk
dc.subjectGenetic variants
dc.subjectOpioid use disorder
dc.titleConcerns About Genetic Risk Testing for Opioid Use Disorder
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hatoum2025Concerns-AAM.pdf
Size:
40.33 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles